Cellarity, a clinical-stage biotechnology company developing Cell State-Correcting therapies through integrated multi-omics and AI modeling, today provided a 2026 corporate outlook and update on key ...
Given the current state of practice and visions for the future (including AI), certain practices should be reevaluated. This ...
Parabilis Medicines, a clinical-stage biopharmaceutical company committed to creating extraordinary medicines for people living with cancer using its Helicontm peptide platform to drug historically ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback